# Omacor for the Treatment of Vascular Dysfunction in Patients With Type 2 Diabetes Mellitus

> **NCT00328536** · PHASE4 · COMPLETED · sponsor: **Ruhr University of Bochum** · enrollment: 34 (estimated)

## Conditions studied

- Atherosclerosis
- Type 2 Diabetes Mellitus

## Interventions

- **DRUG:** Omacor

## Key facts

- **NCT ID:** NCT00328536
- **Lead sponsor:** Ruhr University of Bochum
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-04
- **Primary completion:** 2008-11
- **Final completion:** 2008-11
- **Target enrollment:** 34 (ESTIMATED)
- **Last updated:** 2009-05-08

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00328536

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00328536, "Omacor for the Treatment of Vascular Dysfunction in Patients With Type 2 Diabetes Mellitus". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT00328536. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*